11/06/2024 3:20 PM | Bright Minds Biosciences (Issuer) Chen Bihua (Reporting) Cormorant Asset Management, LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2024 3:06 PM | Bright Minds Biosciences (Subject) Cormorant Asset Management, LP (Filed by)
| Form SC 13G/A | |
11/05/2024 2:21 PM | Bright Minds Biosciences (Subject) McDonald Ian (Filed by)
| Form SC 13D/A | |
11/05/2024 2:25 PM | Bright Minds Biosciences (Subject) McDonald Ian (Filed by)
| Form SC 13D/A | |
10/23/2024 5:01 PM | Bright Minds Biosciences (Subject) Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
10/23/2024 5:09 PM | Bright Minds Biosciences (Subject) Logos Global Management LP (Filed by)
| Form SC 13G | |
10/22/2024 3:02 PM | Bright Minds Biosciences (Subject) PFM Health Sciences, LP (Filed by)
| Form SC 13G/A | |
|
10/22/2024 3:03 PM | Bright Minds Biosciences (Subject) Cormorant Asset Management, LP (Filed by)
| Form SC 13G | |
10/21/2024 8:17 PM | Bright Minds Biosciences (Filer)
| Form D Notice of Exempt Offering of Securities | |
10/18/2024 3:02 PM | Bright Minds Biosciences (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/17/2024 4:07 PM | Bright Minds Biosciences (Issuer) Chen Bihua (Reporting) Cormorant Asset Management, LP (Reporting) Cormorant Global Healthcare Master Fund, LP (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/17/2024 4:11 PM | Bright Minds Biosciences (Issuer) Chen Bihua (Reporting) Cormorant Asset Management, LP (Reporting) Cormorant Global Healthcare Master Fund, LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2024 12:14 PM | Bright Minds Biosciences (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
10/16/2024 10:38 AM | Bright Minds Biosciences (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2024 10:43 AM | Bright Minds Biosciences (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2024 10:36 AM | Bright Minds Biosciences (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2024 11:58 AM | Bright Minds Biosciences (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024 8:15 PM | Bright Minds Biosciences (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/26/2024 7:18 PM | Bright Minds Biosciences (Subject) McDonald Ian (Filed by)
| Form SC 13D/A | |
02/26/2024 7:10 PM | Bright Minds Biosciences (Subject) McDonald Ian (Filed by)
| Form SC 13D/A | |
02/12/2024 8:56 PM | Bright Minds Biosciences (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/18/2024 11:57 AM | Bright Minds Biosciences (Subject) McDonald Ian (Filed by)
| Form SC 13D | |
12/29/2023 3:30 PM | Bright Minds Biosciences (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
12/22/2023 5:26 PM | Bright Minds Biosciences (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/08/2023 5:00 AM | Bright Minds Biosciences (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |